Similar articles

• The antianginal effect of isosorbide mononitrate.

  Bassan M. Bassan M. Am J Cardiol. 1994 Jul 1;74(1):103. doi: 10.1016/0002-9149(94)90506-1. Am J Cardiol. 1994. PMID: 8017298 No abstract available.
• Efficacy of isosorbide mononitrate in angina pectoris.

  Thadani U, de Vane PJ. Thadani U, et al. Am J Cardiol. 1992 Nov 27;70(17):67G-71G. doi: 10.1016/0002-9149(92)90029-x. Am J Cardiol. 1992. PMID: 1449103 Review.
• [Selection of therapy with nitrates in patients with stable effort angina: results of comparative study of common isosorbide dinitrate and long acting preparation of isosorbide-5-mononitrate].

  Martsevich SIu, Semenova IuE, Alimova EV, Dmitrieva nA, Kozyreva MP, Koniakhina IP, Lukina IuV, Egorov VA. Martsevich SIu, et al. Kardiologiia. 2005;45(11):42-5. Kardiologiia. 2005. PMID: 16353064 Clinical Trial. Russian.
• [The efficacy of 2 new drug forms of isosorbide-5-mononitrate in patients with stable stenocardia of effort].

  Metelitsa VI, Martsevich SIu, Kutishenko NP, Kozyreva MP, Blagodatskikh SV, Simkhaev LS, Slastnikova ID, Vakulovskaia MK. Metelitsa VI, et al. Ter Arkh. 1994;66(8):22-5. Ter Arkh. 1994. PMID: 7985147 Russian. No abstract available.
• A sustained release formulation of isosorbide-5-mononitrate with a rapid onset of action.

  Arthur RM, Mehmel H. Arthur RM, et al. Int J Clin Pract. 1999 Apr-May;53(3):205-12. Int J Clin Pract. 1999. PMID: 10665134 Review.